EP Lab

This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices using in EP labs. This includes implantable EP devices, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resychronization therapy (CRT), ablation technologies, left atrial appendage (LAA) occlusion, atrial fibrilation (AF) and Holter monitors.

Medtronic announced new data from the landmark WRAP-IT study published in Heart Rhythm,[1] demonstrating a significantly lower infection risk for patients who develop hematomas after cardiac implantable electronic devices (CIEDs) when the Tyrx Absorbable Antibacterial Envelope is used at implant. The analysis showed an 82% reduction in major CIED infections among patients with the Tyrx Envelope who developed hematomas compared to patients in the control group who developed hematomas.
News | EP Lab
Tyrx Absorbable Antibacterial Envelope Effectively Reduces Infections in Cardiac Device Patients with Hematomas

July 27, 2021 — Medtronic announced new data from the landmark WRAP-IT study published in Heart Rhythm,[1] demonstrating ...

Home July 27, 2021
Home
In the past decade there has been a proliferation of clinical-grade wearable monitors and implantable devices such as pacemakers, ICDs, implantable cardiac monitors, and new pacemaker-like devices that can control hypertension. In the near future, these devices will be tied into a body-wide internet of things for specific patients that can transmit patient data to clinicians wirelessly to enable an integrated, more robust form of telecardiology and telemedicine.
Feature | Telecardiology | Victor Wollesen
Next Generation Cardiac Wearables and Implantables Will Integrate Into Wireless Body Area Networks 

Cardiovascular diseases are among the leading causes of death for people over 65 years old in North America and Europe ...

Home July 23, 2021
Home
A live, 3-D intra-cardiac echo (ICE) ultrasound image from inside the atrium of the heart taken during the first cryoablation EP procedure performed using the technology at Northwestern Medicine. The new Philips Healthcare VeriSight Pro ICE catheter offers superior 2-D and 3-D live image guidance for a wide range of procedures in structural heart disease and electrophysiology (EP), allowing interventionalists to navigate procedures.
Feature | Ultrasound Intra-cardiac Echo (ICE)
Northwestern Medicine First in U.S. to Use Live 3D Intracardiac Echo for EP Procedure

July 21, 2021 — Northwestern Medicine Bluhm Cardiovascular Institute recently became the first cardiovascular program in ...

Home July 21, 2021
Home
ICE image showing the inside of the heart. Mayo Clinic recently became the first to use the next-generation Philips 4-D intracardiac echo imaging catheter. ICE is seeing increased use in structural heart procedures.
News | Ultrasound Intra-cardiac Echo (ICE)
Mayo Clinic First to Use Next Generation 4D ICE System to Guide Structural Heart Procedures

July 16, 2021 — Mayo Clinic recently became the first to use a next-generation 4-D intracardiac echo (ICE) imaging ...

Home July 16, 2021
Home
Medtronic announced clinical trial results from the STROKE AF trial demonstrating the superiority of the Reveal Linq Insertable Cardiac Monitor (ICM) to detect abnormal heartbeats, otherwise known as atrial fibrillation (AF), in both large and small vessel stroke patients compared to standard of care.
News | Implantable Cardiac Monitor (ICM)
Medtronic Insertable Cardiac Monitor Detects Significantly Higher Rates of Atrial Fibrillation in Large and Small Vessel Stroke Patients Compared to Standard of Care

June 13, 2021 — Medtronic announced clinical trial results from the STROKE AF trial demonstrating the superiority of the ...

Home July 14, 2021
Home
ast End Medical announced it received U.S. Food and Drug Administration (FDA) clearance for the company's SafeCross Transseptal Radiofrequency (RF) Puncture and Steerable Balloon Introducer System. The 3-in-1 system, which includes a steerable introducer sheath with an ultra-visible positioning balloon and radiofrequency (RF) puncture dilator, aims to provide a predictable and safe solution for electrophysiology (EP) and structural heart interventions requiring left atrial access.
News | Cath Lab
FDA Clears SafeCross Transseptal RF Puncture and Steerable Balloon Introducer System

July 13, 2021 — East End Medical announced it received U.S. Food and Drug Administration (FDA) clearance for the company ...

Home July 14, 2021
Home
An example of a strain echo from the study showing reduced peak longitudinal/reservoir left atrial strain in a COVID-19 patient who developed atrial fibrillation during admission. Average left atrial strain here is 20% (normal should be above 38%).
News | Cardiovascular Ultrasound
Speckle Tracking Strain Echo May Predict Heart Complications From COVID-19

July 13, 2021 — Researchers at Johns Hopkins Medicine have shown that speckle-tracking strain echocardiograms may ...

Home July 14, 2021
Home
The FDA has cleared Angel Medical Systems' second-generation AngelMed Guardian device. The implantable cardiac device detects and warns patients if they are having an acute coronary syndrome (ACS) event, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery that could potentially double the life of the implanted device
News | Cardiac Diagnostics
FDA Approves AngelMed Enhanced Real-Time Cardiac Monitor for Acute Coronary Syndrome (ACS) Events

July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc. second-generation ...

Home July 01, 2021
Home
The U.S. Food and Drug Administration (FDA) expanded approval for Medtronic's Arctic Front Family of cardiac cryoablation catheters for the treatment of recurrent symptomatic paroxysmal atrial fibrillation (AFib). The indication is for episodes that last less than seven continuous days and the therapy can be used as an alternative to antiarrhythmic drug (AAD) therapy as an initial rhythm control strategy. 
News | Atrial Fibrillation
FDA Expands Arctic Front Family of Cryoablation Catheters for Initial Use in Recurrent Symptomatic Paroxysmal AF

June 23, 2021 — The U.S. Food and Drug Administration (FDA) expanded approval for Medtronic's Arctic Front Family of ...

Home June 23, 2021
Home
GE is integrating artificial intelligence into most of its imaging and information technology software. AI can aid fast critical care decision making. Above left is the vScan Air wireless point-of-care ultrasound system. It integrates AI for immediate, automated assessment of a patient's ejection fraction, right.
Feature | Artificial Intelligence
AI Collaboration is Key to Unlock its Power in Cardiac Care

The digital transformation of healthcare is underway, but it will advance further and faster if key stakeholders work ...

Home June 10, 2021
Home
Some of the top technology news from ACC 2021. Top left, the LAAOS III trial showed benefit when surgeons seal off the LAA during other open heart procedures. Bottom left, the ReCor Paradise renal denervation system helped lower blood pressure in patients who did not respond to medication. Top right, for patients with both heart failure and AFib it makes no differences is therapy is focused on controlling the heart rhythm or heart rate. Bottom right, the FLOWER-MI trial found no benefit to FFR-guided PCI.
Feature | ACC | By Dave Fornell, Editor
Key Cardiology Technology Takeaways at ACC 2021

Here are the top 10 takeaways from the late-breaking studies on cardiovascular technologies presented at the 2021 Americ ...

Home June 08, 2021
Home
Implicity provides a remote cardiac monitoring and research platform used by Independent Diagnostic Testing Facilities and medical centers to deliver high-quality care for patients with connected cardiac devices. On this platform, Implicity aggregates, normalizes and standardizes data from any implantable cardiac device across all manufacturers.
News | EP Lab
Implicity Signs U.S. Distribution Agreement With MicroPort CRM to Expand Remote Monitoring of Various Implanted Cardiac Devices

June 2, 2021 — Implicity, a leader in remote patient monitoring software and cardiac data management solutions ...

Home June 02, 2021
Home
Left, the AcQCross Transseptal Crossing Device offers versatility to be utilized with top sheaths currently used in left atrium EP and structural heart procedures. Right, the AcQMap next-generation mapping catheter integrates high-resolution ultrasound-based imaging and non-contact mapping catheter with improved torque response, handling and maneuverability.
News | EP Lab
Acutus Gains European CE Mark for Suite of Next Generation EP Products

May 25, 2021 — Acutus Medical Inc. announced European CE mark approval for a broad suite of electrophysiology (EP) produ ...

Home May 25, 2021
Home
iRhythm Technologies Inc. announced two new U.S. Food and Drug Administration (FDA) 510(k) clearances — one for a new and improved design of its flagship Zio wearable cardiac monitor, and a second for updated artificial intelligence (AI) capabilities. 
News | Wearables
FDA Clears Smaller iRhythm Monitor with AI Arrhythmia Detection

May 25, 2021 — iRhythm Technologies Inc. announced two new U.S. Food and Drug Administration (FDA) 510(k) clearances — ...

Home May 25, 2021
Home
RAFT-AF study showed type of heart failure may influence treatment strategies for heart rate management vs. arrhythmia control in in patients with heart  heart and atrial fibrillation. #ACC21 #ACC2021
News | Heart Failure
Type of Heart Failure May Influence Optimal Approach for AFib Rhythm Control Versus Rate Control Strategy

May 19, 2021 — Among patients with both heart failure and atrial fibrillation (AFib), treatment strategies focused on ...

Home May 19, 2021
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now